End-of-life care remains aggressive for people with ovarian cancer

C-section babies have microbiome deficit, but catch up over time
5 April 2021
FDA OKs first new ADHD drug in over a decade for children
6 April 2021

End-of-life care remains aggressive for people with ovarian cancer

People with ovarian cancer frequently receive aggressive end-of-life care despite industry guidelines that emphasize quality of life for those with advanced disease, according to a recent study.

Comments are closed.